Kin and Carta Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Kin and Carta wird voraussichtlich ein Umsatzwachstum verzeichnen 9.2% p.a. sinken.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

IT Gewinnwachstum	24.2%
Wachstumsrate der Einnahmen	9.2%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	25 Apr 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Kin and Carta plc's (LON:KCT) Intrinsic Value Is Potentially 19% Below Its Share Price

Oct 19

Newsflash: Kin and Carta plc (LON:KCT) Analysts Have Been Trimming Their Revenue Forecasts

Feb 25

When Should You Buy Kin and Carta plc (LON:KCT)?

Feb 09

Is Kin and Carta plc (LON:KCT) Trading At A 39% Discount?

Jun 14

At UK£2.64, Is Kin and Carta plc (LON:KCT) Worth Looking At Closely?

Mar 31

An Intrinsic Calculation For Kin and Carta plc (LON:KCT) Suggests It's 30% Undervalued

Feb 14

We Think Kin and Carta (LON:KCT) Can Stay On Top Of Its Debt

Dec 16

Estimating The Intrinsic Value Of Kin and Carta plc (LON:KCT)

Sep 21

We Think Kin and Carta (LON:KCT) Has A Fair Chunk Of Debt

May 31

Is Now The Time To Look At Buying Kin and Carta plc (LON:KCT)?

May 04

A Look At The Fair Value Of Kin and Carta plc (LON:KCT)

Mar 30

Returns On Capital At Kin and Carta (LON:KCT) Paint A Concerning Picture

Mar 09

How Much Did Kin and Carta's (LON:KCT) CEO Pocket Last Year?

Feb 16

Is Now The Time To Look At Buying Kin and Carta plc (LON:KCT)?

Jan 29

If You Had Bought Kin and Carta (LON:KCT) Stock Three Years Ago, You Could Pocket A 103% Gain Today

Jan 12

What Kind Of Shareholders Hold The Majority In Kin and Carta plc's (LON:KCT) Shares?

Dec 25

These 4 Measures Indicate That Kin and Carta (LON:KCT) Is Using Debt Extensively

Dec 07

Is Kin and Carta (LON:KCT) Set To Make A Turnaround?

Nov 20

Gewinn- und Umsatzwachstumsprognosen

LSE:KCT - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
7/31/2026	249	N/A	N/A	N/A	1
7/31/2025	216	N/A	N/A	N/A	1
7/31/2024	192	N/A	N/A	N/A	1
7/31/2023	192	-19	-5	-3	N/A
4/30/2023	198	-21	6	8	N/A
1/31/2023	203	-23	17	18	N/A
10/31/2022	197	-19	12	14	N/A
7/31/2022	190	-14	8	10	N/A
4/30/2022	176	-9	4	5	N/A
1/31/2022	162	-3	-1	1	N/A
10/31/2021	145	-5	2	3	N/A
7/31/2021	129	-6	4	6	N/A
4/30/2021	118	-20	11	12	N/A
1/31/2021	107	-35	17	18	N/A
10/31/2020	116	-34	18	19	N/A
7/31/2020	126	-34	19	20	N/A
1/31/2020	135	-3	5	7	N/A
10/31/2019	136	-1	4	7	N/A
7/31/2019	137	1	3	6	N/A
4/30/2019	133	-7	0	4	N/A
1/31/2019	132	-14	-2	2	N/A
10/31/2018	141	-23	5	10	N/A
8/3/2018	150	-32	13	18	N/A
5/3/2018	134	-33	18	22	N/A
2/2/2018	118	-34	23	26	N/A
11/2/2017	140	-26	23	26	N/A
7/28/2017	163	-18	N/A	27	N/A
4/28/2017	241	-13	N/A	26	N/A
1/27/2017	319	-7	N/A	24	N/A
10/27/2016	343	-8	N/A	19	N/A
7/29/2016	368	-8	N/A	14	N/A
4/29/2016	361	-4	N/A	19	N/A
1/29/2016	355	-1	N/A	23	N/A
10/29/2015	350	2	N/A	25	N/A
7/31/2015	345	6	N/A	27	N/A
4/30/2015	341	5	N/A	N/A	N/A
1/30/2015	338	4	N/A	22	N/A
10/30/2014	334	7	N/A	24	N/A
8/1/2014	331	11	N/A	26	N/A
5/1/2014	327	11	N/A	N/A	N/A
1/31/2014	323	11	N/A	36	N/A
10/31/2013	323	8	N/A	34	N/A
8/2/2013	323	4	N/A	31	N/A
5/2/2013	326	6	N/A	26	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von KCT über der Sparquote liegt (1.6%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von KCT schneller wachsen werden als der Markt UK

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von KCT in den nächsten 3 Jahren signifikant steigen werden.

Einnahmen vs. Markt: KCTDie Einnahmen des Unternehmens (9.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (3.8% pro Jahr).

Hohe Wachstumseinnahmen: KCTDie Einnahmen des Unternehmens (9.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von KCT in 3 Jahren voraussichtlich hoch sein wird

Kin and Carta Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 9.0% to UK£1.66

Kin and Carta plc Provides Earnings Guidance for the Fourth Quarter of Fiscal Year 2023

Forecast breakeven date pushed back to 2025

Price target decreased by 28% to UK£2.85

Kin and Carta plc Provides Earnings Guidance for the Year Ending 31 July 2022

Kin and Carta plc Announces Revenue Guidance for the Financial Year Ending 31 July 2022

Recent updates

Kin and Carta Confirms Cancellation of Admission to Trading of its Shares on LSE

Kin and Carta plc(LSE:KCT) dropped from FTSE All-Share Index (GBP)

Kin and Carta plc Launches an Integrated Commerce Accelerator

Kin and Carta plc, Annual General Meeting, Dec 07, 2023

Price target increased by 9.0% to UK£1.66

Full year 2023 earnings: EPS misses analyst expectations

Kin and Carta plc to Report Fiscal Year 2023 Results on Nov 02, 2023

Apax Partners LLP entered into an agreement to acquire Kin and Carta plc (LSE:KCT) from Chris Kutsor,Kelly Manthey,David Bell, John Kerr, Nigel Pocklington, Michele Maher, and others for £203 million.

LSE and FCA to Be Requested Respectively to Cancel Trading in Kin and Carta Shares on FCA's Market for Listed Securities and Listing of Shares from the Official List

Kin and Carta plc's (LON:KCT) Intrinsic Value Is Potentially 19% Below Its Share Price

New major risk - Share price stability

Kin and Carta plc Announces Executive Changes

When Should You Buy Kin and Carta plc (LON:KCT)?

New minor risk - Share price stability

Now 24% undervalued after recent price drop

New minor risk - Share price stability

Market Cool On Kin and Carta plc's (LON:KCT) Earnings Pushing Shares 25% Lower

Returns On Capital Are Showing Encouraging Signs At Kin and Carta (LON:KCT)

Now 24% undervalued after recent price drop

Kin and Carta plc Provides Earnings Guidance for the Fourth Quarter of Fiscal Year 2023

Kin and Carta plc (LSE:KCT) acquired Forecast Data Services Limited.

First half 2023 earnings released: UK£0.072 loss per share (vs UK£0.019 loss in 1H 2022)

Forecast breakeven date pushed back to 2025

Newsflash: Kin and Carta plc (LON:KCT) Analysts Have Been Trimming Their Revenue Forecasts

Price target decreased by 28% to UK£2.85

Kin and Carta plc to Report First Half, 2023 Results on Mar 15, 2023

When Should You Buy Kin and Carta plc (LON:KCT)?

Kin and Carta plc Appoints Nigel Pocklington as Senior Independent Director

Kin and Carta plc, Annual General Meeting, Dec 01, 2022

Full year 2022 earnings released: UK£0.082 loss per share (vs UK£0.03 loss in FY 2021)

Kin and Carta plc Appoints Adam Hasemeyer as CEO of Americas Region

Kin and Carta plc to Report Fiscal Year 2022 Results on Oct 12, 2022

Kin and Carta plc Provides Earnings Guidance for the Year Ending 31 July 2022

Is Kin and Carta plc (LON:KCT) Trading At A 39% Discount?

Kin and Carta plc (LSE:KCT) completed the acquisition of Melon, Inc. from management of Melon and other investors.

Kin and Carta plc announced that it has received $0.817767 million in funding

Now 23% undervalued after recent price drop

At UK£2.64, Is Kin and Carta plc (LON:KCT) Worth Looking At Closely?

Now 22% undervalued after recent price drop

Kin and Carta plc (LSE:KCT) signed an agreement to acquire Melon, Inc. for £23.5 Million from management of Melon and other investors.

Kin and Carta plc (LSE:KCT) agreed to acquire Melon, Inc.

An Intrinsic Calculation For Kin and Carta plc (LON:KCT) Suggests It's 30% Undervalued

Kin and Carta plc Announces Revenue Guidance for the Financial Year Ending 31 July 2022

Now 21% undervalued after recent price drop

We Think Kin and Carta (LON:KCT) Can Stay On Top Of Its Debt

High number of new directors

Price target increased to UK£3.98

Full year 2021 earnings released: UK£0.03 loss per share (vs UK£0.19 loss in FY 2020)

Estimating The Intrinsic Value Of Kin and Carta plc (LON:KCT)

Price target increased to UK£3.34

Price target increased to UK£2.69

Kin and Carta plc Provides Earnings Guidance for the Financial Year Ending 31st July 2021

We Think Kin and Carta (LON:KCT) Has A Fair Chunk Of Debt

Is Now The Time To Look At Buying Kin and Carta plc (LON:KCT)?

Kin and Carta plc announced that it has received $4.919029 million in funding

A Look At The Fair Value Of Kin and Carta plc (LON:KCT)

First half 2021 earnings released: UK£0.03 loss per share (vs UK£0.038 loss in 1H 2020)

Returns On Capital At Kin and Carta (LON:KCT) Paint A Concerning Picture

Kin and Carta plc to Report First Half, 2021 Results on Mar 10, 2021

Kin + Carta Launches Kin + Carta Data Labs

How Much Did Kin and Carta's (LON:KCT) CEO Pocket Last Year?

Price target raised to UK£1.70

Is Now The Time To Look At Buying Kin and Carta plc (LON:KCT)?

If You Had Bought Kin and Carta (LON:KCT) Stock Three Years Ago, You Could Pocket A 103% Gain Today

New 90-day high: UK£1.43

Kin and Carta plc (LSE:KCT) completed the acquisition of Cascade Data Labs, LLC.

What Kind Of Shareholders Hold The Majority In Kin and Carta plc's (LON:KCT) Shares?

Kin and Carta plc (LSE:KCT) entered into an agreement to acquire Cascade Data Labs, LLC for $29.7 million.

Fishawack Medical Communications Limited and an unknown buyer acquired The Health Hive (US) LLC and The Health Hive Group Limited from Kin and Carta plc (LSE:KCT) for £13.8 million.